Evaluation of Immediate Inflammatory Response in Thoracoscopic Esophageal Resection versus Open Approach - A Prospective Study

Chirurgia (Bucur). 2022 Apr;117(2):198-203. doi: 10.21614/chirurgia.2731.

Abstract

Introduction: There is an immune response after major surgery and inflammatory complications following complex surgery have a direct impact on morbidity and mortality. Currently, we do not have clinical tools to predict in which subset of patients a major complication will occur. The aim of this study was to evaluate the immediate dynamics of C-reactive protein (CRP), presepsin and procalcitonin in patients in which esophagectomy was performed either through video assisted thoracic surgery (VATS) or open approach. Methods: We conducted a prospective study on 27 patients with a mean age of 61.48 +-6.80 years, 13 patients with VATS and 14 with open approach, most of the patients were on stage III esophageal cancer (81%) and in all cases neoadjuvant treatment was performed. Results: There were increased levels of CRP, presepsin and procalcitonin after both arms of the study with significantly higher values for the open approach and with the same dynamic curves. In 3 cases there were extremely elevated levels of procalcitonin in the absence of a septic complication, in all cases a major complication occurred. Conclusion: Video assisted thoracoscopic esophageal mobilization induces a less immune response, even with the association of laparotomy. An elevated postoperative procalcitonin level can be an early indicator of a major postoperative complication.

Keywords: VATS; esophagealcancer; esophagectomy; immuneresponse; thoracoscopy.

MeSH terms

  • Aged
  • C-Reactive Protein
  • Esophageal Neoplasms* / surgery
  • Esophagectomy / adverse effects
  • Humans
  • Lipopolysaccharide Receptors
  • Middle Aged
  • Peptide Fragments
  • Postoperative Complications / etiology
  • Procalcitonin*
  • Prospective Studies
  • Retrospective Studies
  • Thoracic Surgery, Video-Assisted / adverse effects
  • Thoracoscopy / adverse effects
  • Treatment Outcome

Substances

  • Lipopolysaccharide Receptors
  • Peptide Fragments
  • Procalcitonin
  • presepsin protein, human
  • C-Reactive Protein